KawanishiH., MoriishiM., TsuchiyaS.Experience of 100 surgical cases of encapsulating peritoneal sclerosis: investigation of recurrent cases after surgery.Adv Perit Dial2006; 22: 60–4.
6.
NakamotoH., KawaguchiY., SuzukiH.Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan.Adv Perit Dial2002; 18: 119–23.
7.
KawanishiH., KawaguchiY., FukuiH., HaraS., ImadaA., KuboH.Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.Am J Kidney Dis2004; 44: 729–37.
8.
ChalasaniR., MarellaP.Sclerosing encapsulating peritonitis in a 47-year-old woman.Kidney Int2006; 70: 1673.
9.
SachdevA., UsatoffV., ThaowC.Sclerosing encapsulating peritonitis and methotrexate.Aust N Z J Obstet Gynaecol2006; 46: 58–9.
10.
ThirunavukarasuT., SaxenaR., AnijeetH., PaiP.Encapsulating peritoneal sclerosis presenting with recurrent ascites and tamoxifen: case reports and review of the literature.Ren Fail2007; 29: 775–6.
11.
LafranceJ., LetourneauI., OuimetD., BonnardeauxA., LeblancM., MathieuN.Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy.Am J Kidney Dis2008; 51: e7–10.
12.
SummersA.M., ClancyM.J., SyedF., HarwoodN., BrenchleyP., AugustineT.Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.Kidney Int2005; 68: 2381–8.
13.
CampbellS., ClarkeP., HawleyC., WiganM., KerlinP., ButlerJ.Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features.Am J Kidney Dis1994; 24: 819–25.
14.
RigbyR., HawleyC.Sclerosing peritonitis: the experience in Australia.Nephrol Dial Transplant1998; 13: 154–9.
15.
OulesR., ChallahS., BrunnerF.P.Case-control study to determine the cause of sclerosing peritoneal disease.Nephrol Dial Transplant1988; 3: 66–9.
16.
MaletC., GompelA., YanevaH., CrenH., FidjiN., MowszowiczI.Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies.J Clin Endocrinol Metab1991; 73: 8–17.
17.
AshcroftG.S., DodsworthJ., Van BoxtelE., TarnuzzerR., HoranM., SchultzG.Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels.Nat Med1997; 3: 1209–15.
18.
WiczykH., GrowD., AdamsL., O'SheaD., ReeceM.Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors.Fertil Steril1998; 69: 511–16.
19.
GrowD.R., CoddingtonC.C., HsiuJ., MikichY., HodgenG.Role of hypoestrogenism or sex steroid antagonism in adhesion formation after myometrial surgery in primates.Fertil Steril1996; 66: 140–7.
20.
Montanino-OlivaM., MetzgerD.A., LucianoA.A.Use of medroxyprogesterone acetate in the prevention of postoperative adhesions.Fertil Steril1996; 65: 650–4.
21.
WrightJ.A., Sharpe-TimmsK.L.Gonadotropin-releasing hormone agonist therapy reduces postoperative adhesion formation and reformation after adhesiolysis in rat models for adhesion formation and endometriosis.Fertil Steril1995; 63: 1094–100.
22.
GuestS.Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences.Perit Dial Int2009; 29: 252–5.
23.
RuffyM., KunnavatanaS., KochR.Effects of tamoxifen on normal human dermal fibroblasts.Arch Facial Plast Surg2006; 8: 329–32.
24.
PayneW.G., KoF., AnspaughS., WheelerC.K., WrightT.E., RobsonM.C.Down-regulating causes of fibrosis with tamoxifen: a possible cellular/molecular approach to treat rhinophyma.Ann Plast Surg2006; 56: 301–5.
25.
SchneiderG., KirschnerM.A., BerkowitzR., ErtelN.H.Increased estrogen production in obese men.J Clin Endocrinol Metab1979; 48: 633–8.
26.
LovesS., Ruinemans-KoertsJ., de BoerH.Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism.Eur J Endocrinol2008; 158: 741–7.
